Purpose: To evaluate the early clinical outcomes of a new diffractive extended depth-of-focus (EDOF) intraocular lens (IOL). Methods: Prospective case series enrolling patients undergoing cataract surgery with implantation of the EDOF IOL AT LARA (Carl Zeiss Meditec, Jena, Germany). Distance, intermediate and near visual acuity were evaluated during a follow-up of 1 month. Likewise, defocus curve, binocular mesopic contrast sensitivity, perception of photic phenomena, patient satisfaction and spectacle independence were assessed. Results: The study enrolled 38 eyes of 19 patients with a mean age of 69.5 years. A significant reduction of manifest refraction and improvement in corrected distance visual acuity (CDVA) was observed with surgery (p < 0.001). All eyes achieved a 1-month postoperative binocular CDVA of 20/20 or better. Likewise, all eyes achieved a DCIVA of 20/30 or better at 1 month postoperatively, and a total of 92.1% achieved DCNVA of 20/40 or better. Concerning refractive predictability, 97.4% of eyes had a 1-month postoperative spherical equivalent within ±0.50 D. The level of patient satisfaction with distance, intermediate and near vision was high, with 95% of patients reporting that they would have the same surgical procedure with the same IOL again. Difficulties in night driving or associated to halos were low. A total of 89% of patients reported to be spectacle independent postoperatively. Conclusions: The EDOF IOL AT LARA is able to provide a functional restoration of the visual function across distances after cataract surgery, with very high levels of patient satisfaction and minimal incidence of photic phenomena.
Introduction
In the last years, a new concept of presbyopia-correcting intraocular lenses How to cite this paper: Poyales, F., Garzón, N., Poyales, C. and Poyales, B. (IOLs) has been developed and widely expanded in clinical practice, the extended depth of focus (EDOF) IOL technology [1] . This type of implants is aimed at providing functional vision at different distances while minimizing the incidence of photic phenomena [1] , as the presence of secondary out-of-focus images corresponding to different foci is avoided due to the presence of a continuous range of focus [2] . In other words, no clearly differentiated foci are generated by EDOF IOLs as it is the case with multifocal IOLs [3] . It should be considered that photic phenomena are one of the main causes of dissatisfaction after cataract surgery with implantation of multifocal IOLs [4] and one of the main reasons leading surgeons to multifocal IOL explantation [5] .
The main basis of EDOF technology is the use of an optical design providing a more reduced near addition of the IOL while maintaining a continuous range of functional vision across intermediate and near distances. This can be achieved by means of a diffractive [6] [7] or a refractive platform [6] [8] aimed at controlling the level of spherical or coma aberration. Different studies have shown the clinical performance of EDOF IOLs, reporting good visual and contrast sensitivity outcomes, with high levels of patient satisfaction [9] - [14] . Concerning photic phenomena outcomes, whereas some comparative trials have found no significant differences between multifocal and EDOF IOLs [9] [11] [12] , others have found a lower incidence of photic phenomena with EDOF designs compared to trifocal IOLs [13] . The aim of the current study was to evaluate the clinical outcomes of a new model of diffractive EDOF IOL in terms of visual acuity across different distances, contrast sensitivity, photic phenomena and patient satisfaction.
Methods

Patients
This prospective case series enrolled patients undergoing cataract surgery with implantation of the EDOF IOL AT LARA (Carl Zeiss Meditec, Jena, Germany).
Inclusion criteria were cataract eyes with no comorbidity, availability, willingness and sufficient cognitive awareness to comply with examination procedures, and signed informed consent. Exclusion criteria were irregular astigmatism, corneal astigmatism of more than 1.00D, patient age below 40 years, difficulty for cooperation (distance from their home, general health condition), acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus with retinopathy, immunocompromised, glaucoma etc…), any ocular comorbidity, history of ocular trauma or prior ocular surgery including refractive procedures, capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, chronic Uveitis, Marfan's syndrome), pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions), age-related macular degeneration (AMD) suspicious eyes, and/or complicated surgery. All patients were informed about the study and provided 
Examinations
All patients underwent a comprehensive preoperative ophthalmological examination including measurement of uncorrected and corrected distance visual acuity (UDVA and CDVA), keratometry, optical biometry (IOLMaster, Carl Zeiss Meditec AG, Germany), manifest refraction, biomicroscopy, Goldmann applanation tonometry, and dilated fundoscopy. Postoperatively, patients were evaluated the day after surgery, and at 1 week and 1 month after surgery. . Patient satisfaction and quality of life were determined by means of a questionnaire, which was completed by the patients at the last follow-up visit. Questions included satisfaction about: adaption between photopic and mesopic conditions, ability to find the correct distance, night driving, vision during the day, halos, adaption between far and near vision and vice versa, as well as general satisfaction for distance, intermediate and near vision, and overall satisfaction. Patients were also asked whether they would perform the same surgery again and whether they need to wear glasses for the daily tasks. Each subscale score was converted to a score between 0 and 5, with higher scores indicating better results. Finally, halometry was also measured at this visit.
Surgical Technique
An experienced surgeon (FP) performed all surgeries using a standard technique of sutureless phacoemulsification. Topical anaesthesia was initially administered, and pharmacologic mydriasis was induced. Once pupillary dilation was achieved, the surgical procedure was initiated with a clear cornea microincision of around 2.2 mm with a diamond knife and a paracentes is 60˚ -90˚ clockwise from the main incision. The IOL was implanted through the main incision using a specific injector. Postoperative pharmacological treatment consisted of a combination of antibiotic and steroidal anti-inflammatory drops. Likewise, non-steroidal anti-inflammatory drops were prescribed to prevent macular edema. 
Statistical Analysis
Results
The sociodemographic and clinical characteristics of the patients is shown in Table 1 . Concerning refractive predictability, a total of 97.4% of eyes had a 1-month postoperative spherical equivalent within ±0.50 D. Figure 1 shows the mean binocular defocus curve at 1 month after surgery. As shown, a distance-corrected visual acuity over 0.2 logMAR was achieved for defocus levels up to −2 D. Table 3 shows the mean scores of different aspects of quality of vision and patient satisfaction using the subjective questionnaire. Good scores were obtained for all aspects, with the lowest scores associated to night driving and halos. A total of 95% (18) of the Table 3 . Quality of vision and patient satisfaction outcomes obtained using a subjective questionnaire at 1 month after surgery (score from 0 = worst score to 5 = best score). 
Visual and Refractive Outcomes
Quality of Vision and Patient Satisfaction Outcomes
Discussion
This is one of the first clinical studies reporting the clinical outcomes obtained with the EDOF IOL AT LARA, which is based on a diffractive platform. Distance visual acuity is excellent with this EDOF IOL, with a 1-month postoperative UDVA and CDVA of 0.08 ± 0.10 and 0.00 ± 0.02, respectively. Therefore, Open Journal of Ophthalmolog tions. This confirms one of the potential advantages of EDOF IOLs, the generation of less disturbing photic phenomena. Hamid and Sokwala [13] reported in a comparative study that the perception of halos with a trifocal IOL was more disturbing compared to EDOF IOLs. However, other authors such as Escandón-García et al. [22] found in a prospective case series that objective dysphotopsia measured with a light distortion analyzer was not reduced in eyes implanted with EDOF IOLs compared to trifocal IOLs. Possibly, in some patients with specific characteristics, the tolerance to the double halo generated by trifocal IOLs [23] is similar to that associated to the halos of lower magnitude generated by EDOF IOLs. Future studies should investigate this further.
Conclusion
The EDOF IOL AT LARA is able to provide a restoration of the visual function across distances after cataract surgery, with very high levels of patient satisfaction. The near visual performance obtained with this IOL is more limited than that obtained with multifocal IOLs, but it is within a functional range allowing the patient to perform most of the daily activities without the need for glasses.
As expected according to the design of the IOL, the incidence of photic phenomena was minimal, with low impact on night driving. Future studies should confirm all these outcomes in larger samples over a longer follow-up period.
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